A Multicenter, Open-Label, Randomized, Active-Controlled Parallel Groups Study Comparing the Efficacy and Safety of Temodal vs Semustine in the Treatment of Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma.
Phase of Trial: Phase III
Latest Information Update: 19 May 2017
At a glance
- Drugs Temozolomide (Primary) ; Semustine
- Indications Astrocytoma; Glioblastoma
- Focus Registrational; Therapeutic Use
- Sponsors Schering-Plough
- 13 Oct 2008 New trial record.